Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Robert Kridel, Barbara Meissner, Sanja Rogić, +16

Blood

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

David D. W. Twa, Fong Chun Chan, Susana Ben‐Neriah, +14

Blood

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

Jay Gunawardana, Fong Chun Chan, Adèle Telenius, +19

Nature Genetics

Lymphoid NeoplasiaHodgkin LymphomaSomatic VariantRecurrent Somatic MutationsPathology +4

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

Joshua W.D. Tobin, Colm Keane, Jay Gunawardana, +21

Journal of Clinical Oncology

Meningococcal Porin PorB Binds to TLR2 and Requires TLR1 for Signaling

Paola Massari, Alberto Visintin, Jay Gunawardana, +4

The Journal of Immunology

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Maher K. Gandhi, Thanh Hoang, Soi Cheng Law, +24

Blood

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma

Deepak Bararia, Johannes Adrian Hildebrand, Sebastian Stolz, +35

Cell Reports

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, +10

Blood

The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma

Colm Keane, Joshua W.D. Tobin, Jay Gunawardana, +11

European Journal Of Haematology

Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation

Elena Viganò, Jay Gunawardana, Anja Mottok, +22

Blood